Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 16, 2020 11:04AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
KBC...So what are you saying? State your bottom line.
Koo